Abivax (AAVXF) Cash from Investing Activities (2024 - 2026)

Abivax has reported Cash from Investing Activities for 3 years, with the latest figure at $579519.1 in Q1 2026.

• On a quarterly basis, Cash from Investing Activities fell 49.08% year-over-year to $579519.1 in Q1 2026; TTM through Mar 2026 was -$9.5 billion, a 156.63% decrease from a year earlier, with the FY2025 full-year figure at -$9.5 billion, down 156.62% from the prior year.
• Cash from Investing Activities was $579519.1 for Q1 2026 at Abivax, up from -$9.5 billion in the prior quarter.
• The five-year high for Cash from Investing Activities was $16.8 billion in Q4 2024, with the low at -$9.5 billion in Q4 2025.
• Average Cash from Investing Activities over 3 years is $811.9 million, with a median of $1.9 million recorded in 2024.
• The largest YoY upside for Cash from Investing Activities was 99.75% in 2025 against a maximum downside of 156.71% in 2025.
• Over 3 years, Cash from Investing Activities stood at $16.8 billion in 2024, then slumped by 156.71% to -$9.5 billion in 2025, then jumped by 100.01% to $579519.1 in 2026.
• The last three Cash from Investing Activities figures came in at $579519.1 (Q1 2026), -$9.5 billion (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.